Evidence mapPaperPMID 41814110Full record

ArticleCancer epidemiology2026

Cancer incidence in Addis Ababa, 2018-2022: The only population based cancer registry in Ethiopia.

Muluken Gizaw, Donald Maxwell Parkin, Solomon Asmare, KaleEgziabher Lukas, Sefonias Getachew, Alemnew Destaw, Biying Liu, Mathewos Assefa, Adamu Addissie, Eva Johanna Kantelhardt

Abstract read
In one paragraph

Article in Cancer epidemiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Muluken GizawDepartment of Epidemiology and Biostatistics, School of Public Health, Addis Ababa University, Addis Ababa, Ethiopia; Global Health Working Group, Martin-Luther-University Halle-Wittenberg, Germany; NCD Working Group, School of Public Health, Addis Ababa University, Ethiopia. Electronic address: muluken.gizaw@aau.edu.et.
Donald Maxwell ParkinInternational Agency for Research on Cancer, Lyon, France; Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.
Solomon AsmareDepartment of Oncology, Addis Ababa Cancer Registry, College of Health Sciences, Addis Ababa University, Ethiopia.
KaleEgziabher LukasDepartment of Oncology, Addis Ababa Cancer Registry, College of Health Sciences, Addis Ababa University, Ethiopia.
Sefonias GetachewDepartment of Epidemiology and Biostatistics, School of Public Health, Addis Ababa University, Addis Ababa, Ethiopia; Global Health Working Group, Martin-Luther-University Halle-Wittenberg, Germany; NCD Working Group, School of Public Health, Addis Ababa University, Ethiopia.
Alemnew DestawDepartment of Epidemiology and Biostatistics, School of Public Health, Addis Ababa University, Addis Ababa, Ethiopia; Global Health Working Group, Martin-Luther-University Halle-Wittenberg, Germany.
Biying LiuAfrican Cancer Registry Network, United Kingdom.
Mathewos AssefaDepartment of Oncology, Addis Ababa Cancer Registry, College of Health Sciences, Addis Ababa University, Ethiopia.
Adamu AddissieDepartment of Epidemiology and Biostatistics, School of Public Health, Addis Ababa University, Addis Ababa, Ethiopia; Global Health Working Group, Martin-Luther-University Halle-Wittenberg, Germany; NCD Working Group, School of Public Health, Addis Ababa University, Ethiopia.
Eva Johanna KantelhardtGlobal Health Working Group, Martin-Luther-University Halle-Wittenberg, Germany; Department of Gynaecology, Martin-Luther-University, Halle-Wittenberg, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCancer remains a significant public health challenge worldwide, with developing regions bearing a disproportionately higher burden. In Ethiopia, the scarcity of data from population-based cancer registries (PBCR) has limited a comprehensive understanding of the cancer profile in the country.

methodsData from the PBCR in Addis Ababa, covering approximately 3.7 million people (2020), about 3% of the Ethiopian population, were analyzed for cancer cases diagnosed between 2018 and 2022. Age-standardized incidence rates (ASR) for common cancers were calculated and compared with estimated rates in East Africa, West Africa, the Black population in the USA, and global averages.

resultsA total of 14,053 cancer cases were recorded, with 4584 cases in men (ASR: 66.5 per 100,000) and 9469 cases in women (ASR: 113.5 per 100,000). Among males, the three most commonly diagnosed cancers were colorectal cancer (14.3% of all male cancers, with an ASR of 9.8 per 100,000), prostate cancer (12.9%, ASR 11.8 per 100,000), and mouth and pharynx cancer (6.6%, ASR 3.9 per 100,000). In females, the three most commonly diagnosed cancers were breast cancer (38.8% of all female cancers, with an ASR of 39.8 per 100,000), cervical cancer (14.3%, ASR 18.9 per 100,000), and colorectal cancer (7.2%, ASR 8.9 per 100,000).

conclusionThis study reveals a higher cancer burden in women, with breast and cervical cancers accounting for over two-thirds of all cancer cases, consistent with cancer patterns in other East African regions. The lower incidence of prostate and liver cancers points to possible under diagnosis or underreporting, highlighting the need for enhanced diagnostic and screening capacities. The relatively high incidence of colorectal cancer emphasizes the importance of targeted awareness and screening programs, particularly in urban areas like Addis Ababa.

Indexed as

NeoplasmsAdolescentAdultAgedChildChild, PreschoolEthiopiaFemaleHumansIncidenceInfantMaleMiddle AgedRegistriesYoung AdultAge-standardized incidence rateCancer incidenceEthiopiaPopulation-based cancer registry

Identifiers

PMID41814110
PMCPMC13219234

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.